UBS O'Connor’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History
Bought
Maintained
Sold
Other funds holding THAC
SCM
FTCM
PAMP
PC
WCMNY
SCM
GCL
UBS O'Connor's THAC Position: Q4 2022 in Review
UBS O'Connor sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q4 2022, closing a stake of 238,623 shares — an estimated $2.42M sold.
UBS O'Connor first reported a position in THAC in Q4 2021 and held it in 3 quarters. The position peaked at $2.64M in Q2 2022. 48 funds tracked by Wall St. Rank hold THAC as of Q4 2022.
- UBS O'Connor reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q4 2022 after selling out during the quarter.
- UBS O'Connor sold 238,623 Thrive Acquisition Corporation Class A ordinary shares shares in Q4 2022, an estimated $2.42M.
- UBS O'Connor first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q4 2021 and held it in 3 quarters.
- UBS O'Connor's Thrive Acquisition Corporation Class A ordinary shares position peaked at $2.64M in Q2 2022.
- 48 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q4 2022.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.